These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19489991)

  • 1. The ageing heroin user: career length, clinical profile and outcomes across 36 months.
    Darke S; Mills KL; Ross J; Williamson A; Havard A; Teesson M
    Drug Alcohol Rev; 2009 May; 28(3):243-9. PubMed ID: 19489991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
    Darke S; Ross J; Williamson A; Teesson M
    Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine use among heroin users: baseline use, current use and clinical outcome.
    Darke S; Ross J; Mills K; Teesson M; Williamson A; Havard A
    Drug Alcohol Rev; 2010 May; 29(3):250-5. PubMed ID: 20565516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence.
    Mills KL; Teesson M; Ross J; Darke S
    Addiction; 2007 Mar; 102(3):447-54. PubMed ID: 17298653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?
    Kelley MS; Chitwood DD
    Soc Sci Med; 2004 May; 58(10):2083-92. PubMed ID: 15020021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Mills KL; Teesson M; Darke S; Ross J; Lynskey M
    J Subst Abuse Treat; 2004 Jul; 27(1):67-73. PubMed ID: 15223096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2005 May; 78(2):177-86. PubMed ID: 15845321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin use, dependence, and attitudes to treatment in non-treatment-seeking heroin users: a pilot study.
    Dean AJ; Saunders JB; Bell J
    Subst Use Misuse; 2011; 46(4):417-25. PubMed ID: 20735218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
    Havard A; Teesson M; Darke S; Ross J
    J Subst Abuse Treat; 2006 Jun; 30(4):355-62. PubMed ID: 16716851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral health status of heroin users in a rehabilitation centre in Hubei province, China.
    Du M; Bedi R; Guo L; Champion J; Fan M; Holt R
    Community Dent Health; 2001 Jun; 18(2):94-8. PubMed ID: 11461065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental health outcomes following naltrexone implant treatment for heroin-dependence.
    Ngo HT; Tait RJ; Arnold-Reed DE; Hulse GK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):605-12. PubMed ID: 17229510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heroin abuse among Danish prisoners on remand. II. Consequences related to form of administration].
    Andersen HS; Sestoft DM; Lillebaek T; Gabrielsen G
    Ugeskr Laeger; 1996 Aug; 158(34):4754-8. PubMed ID: 8801683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young heroin users in Baltimore: a qualitative study.
    Gandhi DH; Kavanagh GJ; Jaffe JH
    Am J Drug Alcohol Abuse; 2006; 32(2):177-88. PubMed ID: 16595322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.